HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice.

Abstract
Menopausal ovaries undergo morphological changes, known as ovarian aging, which are implicated in the high incidence of ovarian cancer occurring during the perimenopausal and immediate postmenopausal periods. The germ cell-deficient Wv mice recapitulate these postmenopausal alterations in ovarian morphology and develop tubular adenomas. We demonstrate that a reduction of cyclooxygenase 2 gene dosage rescued the ovarian aging phenotype of the Wv mice, whereas homozygous deletion was accompanied by a compensatory increase in ovarian cyclooxygenase 1 expression and prostaglandin E(2) synthesis. Cyclooxygenase inhibitors also reduced the tumor phenotype in a preliminary study. These findings suggest that increased cyclooxygenase activity contributes to the preneoplastic morphological changes of the ovarian surface epithelium, which can be reversed by a reduction of gene dosage achieved by either genetic or pharmacological approaches.
AuthorsWan-Lin Yang, Kathy Qi Cai, Jennifer L Smedberg, Elizabeth R Smith, Andres Klein-Szanto, Thomas C Hamilton, Xiang-Xi Xu
JournalThe American journal of pathology (Am J Pathol) Vol. 170 Issue 4 Pg. 1325-36 (Apr 2007) ISSN: 0002-9440 [Print] United States
PMID17392171 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Celecoxib
  • Dinoprostone
  • Indomethacin
Topics
  • Adenoma (genetics, metabolism, pathology)
  • Aging (pathology)
  • Animals
  • Blotting, Western
  • Celecoxib
  • Cell Transformation, Neoplastic (drug effects)
  • Cyclooxygenase 2 (deficiency, genetics, metabolism)
  • Cyclooxygenase Inhibitors (administration & dosage, pharmacology)
  • Dinoprostone (metabolism)
  • Epithelium (metabolism, pathology)
  • Female
  • Gene Dosage
  • Heterozygote
  • Homozygote
  • Humans
  • Inbreeding
  • Indomethacin (administration & dosage, pharmacology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Ovarian Neoplasms (genetics, metabolism, pathology)
  • Ovary (drug effects, metabolism, pathology)
  • Phenotype
  • Pyrazoles (administration & dosage, pharmacology)
  • Sulfonamides (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: